AminoChain

When people donate biospecimens—whether it’s blood, tissue, or DNA—they do so with the hope that their contribution will lead to life-saving discoveries. But once those samples leave their hands, they often disappear into a complex system, leaving donors without a clear picture of where their specimens go, how they’re used, or what outcomes they might have helped achieve. For decades, biospecimens have been the foundation of groundbreaking research, but the system supporting their use hasn’t kept pace with the values of transparency and patient engagement. The disconnect isn’t a result of bad actors but of outdated processes that make it difficult for both patients and institutions to fully benefit from collaboration. This raises an important question: shouldn’t those who donate to science have the ability to remain connected to their contributions? Imagine a future where patients can track their biospecimens, learn about the impact they’ve had, and know that their involvement truly matters. A system where trust and accountability bridge the gap between donors, researchers, and institutions—a system that works for everyone. At AminoChain, we’re working to create that future. By making biospecimen use more transparent and traceable, we aim to empower donors and build a collaborative ecosystem where patients remain at the heart of scientific progress.

Many patients donate biospecimens without knowing how their samples are used. With AminoChain, we’re setting a new standard for transparency and traceability in research. How critical is transparency in biospecimen research to you? ??Essential – donors deserve to know and track usage ??Very important – transparency builds trust and accountability ??Somewhat important – but secondary to research progress ??Not a priority – the focus should be on advancing science Vote in the poll and share your thoughts in the comments!

Imagine needing a critical biospecimen for your research—only to spend months navigating endless emails, paperwork, and regulatory hurdles just to get it. That’s the reality researchers face today. The process is slow, outdated, and frustrating. Researchers often spend weeks just exchanging emails to check if the biospecimens they need are even available. Once they find a potential match, they face complex negotiations and lengthy licensing agreements that delay approvals even further. On top of that, strict regulatory requirements create additional barriers, making what should be a straightforward process feel like an endless maze of paperwork and waiting. With AminoChain, we’re changing that. The Specimen Center makes searching for and acquiring biospecimens as easy as a Google search—so researchers can focus on breakthroughs, not bureaucracy. Faster access = Faster discoveries = More lives saved. ?? Learn more: https://aminochain.io/

The Specimen Center is just the beginning. At AminoChain, we’re building more than a platform—we’re creating a new bioeconomy where biospecimen research is faster, more accessible, and truly patient-centric. Imagine a world where biobanks, researchers, and medical institutions are seamlessly connected through decentralized applications—powering clinical recruitment, AI-driven research, and federated learning, all while ensuring data security and compliance with HIPAA and GDPR standards. By establishing the world’s first decentralized, compliant blockchain for healthcare data, we aim to revolutionize how biosamples and research data are shared, tracked, and utilized—ensuring that patients, institutions, and scientists all benefit from scientific advancements. This is the future of biobanking—transparent, efficient, and built on trust.

Biobanks are the foundation of medical research, yet too often, valuable specimens remain underutilized, procurement is slow and complex, and compliance requirements create operational headaches. With AminoChain’s Specimen Center, biobanks can finally overcome the challenges of slow procurement and limited visibility. By listing your inventory, you can connect with top researchers actively searching for biospecimens, ensuring that valuable samples don’t go unused. Our platform streamlines the entire process, cutting down delays with an intuitive inquiry and procurement system that makes transactions seamless. You remain in full control, with complete oversight of sample distribution and compliance, so you can operate with confidence. Most importantly, your specimens will contribute to lifesaving discoveries, maximizing their impact in the scientific community. It’s time to make biospecimen access faster, easier, and more efficient. If you’re a provider interested in listing your inventory on the AminoChain Specimen Center, fill out the form here: ?? https://lnkd.in/dvtgAbd7

Imagine a world where biospecimen discovery is seamless, ethical, and transparent – where researchers can access high-quality samples in real-time, patients can track their contributions, and biorepositories can efficiently manage and share specimens without bottlenecks. That’s exactly what AminoChain is building. We connect biorepositories, researchers, and patients on a single platform, transforming how biosamples are donated, tracked and utilized in groundbreaking research. With AminoChain, researchers can effortlessly find and request biospecimens in minutes instead of weeks, accelerating the pace of discovery and innovation. Biobanks gain increased visibility while optimizing inventory management, automating compliance processes, and reducing inefficiencies in specimen distribution. This means: ?? More transparency ?? Faster discoveries ?? Ethical innovation The future of biospecimen research starts here. Join us.? ?? https://aminochain.io

Biobanks are the backbone of biomedical research, but they’re operating in silos. Researchers face major barriers in accessing bio-specimens: ?? Limited visibility across fragmented repositories ? Slow, bureaucratic procurement processes ?? Lack of transparency in consent & compliance ?? High costs & inefficiencies due to middlemen At AminoChain, we’re fixing this. Introducing the Specimen Center; a federated platform connecting biobanks, clinical sites, and research institutions for seamless bio-specimen discovery & procurement. ? Key Features: ?? Full provider control over MTAs & access ?? Real-time inventory updates via LIMS integration ?? AI-powered search & analytics for precision research ?? Faster, direct procurement—no middlemen ?? Launching May 14, 2025! Mark your calendar and join us in building decentralized biobanking by singing up for our waitlist here: https://lnkd.in/dvtgAbd7 And read more on our blog post on the Specimen Center release here: https://lnkd.in/d_dhJtxk

After 2 years of building in silence we’re so excited to finally share AminoChain with the world! Every year, patients donate millions of cancer samples to scientific research. These samples are stored in biobanks and distributed to researchers and bio-pharma companies to study diseases and create novel therapeutics. Biobanks are powerhouses of precision medicine as they catalog thousands of diseases and standardize research output. However, biobanks only use an average of 10% of the samples in their inventories, and it takes up to 2 months for a pharma company to find, acquire and license a sample from a biobank. There is little to no effective infrastructure for bio-sample and data sharing between institutions, and worst of all, patients often do not know how their samples are used in scientific research. AminoChain is a blockchain protocol that connects enterprise medical institutions, and on which healthcare applications can be built. The first application built on AminoChain is a bio-sample marketplace that lets researchers query for and license samples across a network of biobanks. The best part: any hospital or biobank can enable features that let patients and bio-sample donors track how their samples are used in scientific research, and patients can share in the commercial and scientific value that is derived from their donated samples. While the first application built on AminoChain is a bio-sample marketplace, the protocol can power hundreds of further used-owned and decentralized healthcare applications. AminoChain is building an entirely new on-chain bioeconomy, where patients are the first to benefit from their participation in scientific research. We’re very excited to announce our $5M seed round led by a16z crypto, bringing our total funding to date to $7.8M. See below to read more about AminoChain and our latest funding round, and to view our open roles. https://lnkd.in/dSZdpbpY https://lnkd.in/dTXQgsEU

Firing up all cylinders at AminoChain! Full stackers and Blockchain Engineers, if you are game to be part of founding team to build, ship and launch, I'd love to speak with you. Team is keen to set up presence in NY, brining great people together and build a robust team culture. Hybrid arrangement in NY is a sure must!